| 000 | 01911 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516074318.0 | ||
| 264 | 0 | _c20120604 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1946-6242 | ||
| 024 | 7 |
_a10.1126/scitranslmed.3003316 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKatayama, Ryohei | |
| 245 | 0 | 0 |
_aMechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers. _h[electronic resource] |
| 260 |
_bScience translational medicine _cFeb 2012 |
||
| 300 |
_a120ra17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnaplastic Lymphoma Kinase |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCrizotinib |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xgenetics |
| 700 | 1 | _aShaw, Alice T | |
| 700 | 1 | _aKhan, Tahsin M | |
| 700 | 1 | _aMino-Kenudson, Mari | |
| 700 | 1 | _aSolomon, Benjamin J | |
| 700 | 1 | _aHalmos, Balazs | |
| 700 | 1 | _aJessop, Nicholas A | |
| 700 | 1 | _aWain, John C | |
| 700 | 1 | _aYeo, Alan Tien | |
| 700 | 1 | _aBenes, Cyril | |
| 700 | 1 | _aDrew, Lisa | |
| 700 | 1 | _aSaeh, Jamal Carlos | |
| 700 | 1 | _aCrosby, Katherine | |
| 700 | 1 | _aSequist, Lecia V | |
| 700 | 1 | _aIafrate, A John | |
| 700 | 1 | _aEngelman, Jeffrey A | |
| 773 | 0 |
_tScience translational medicine _gvol. 4 _gno. 120 _gp. 120ra17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/scitranslmed.3003316 _zAvailable from publisher's website |
| 999 |
_c21491725 _d21491725 |
||